Fermenta Biotech’s Dahej manufacturing facility secures EU GMP certification

New Delhi: Fermenta Biotech Limited (FBL), an active player in the field of Active Pharmaceutical Ingredients (API), has announced that its Dahej manufacturing facility in Gujarat, India, has been awarded the prestigious European Union Good Manufacturing Practice (EU GMP) certification.

The certification, granted by the Competent Authority of Germany, follows a successful inspection conducted in March 2024.

Commenting on the achievement, Prashant Nagre, Managing Director of Fermenta Biotech, said, “We are pleased with the positive outcome of the recent EU GMP inspection at our Dahej Manufacturing Facility in Gujarat. The certificate of GMP compliance underscores our commitment to global standards of quality, compliance, and consistency in manufacturing.”

The EU GMP certification is an essential requirement for pharmaceutical companies aiming to supply products in the European Union, assuring that manufacturing practices meet the stringent quality guidelines laid out by the European Medicines Agency (EMA).

With this latest certification, the company is well-positioned to expand its reach in regulated markets, delivering high-quality products that meet international benchmarks.